Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premal Lulla

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Human Vaccines & Immunotherapeutics|August 6, 2024
Approved CAR-T therapies have reproducible efficacy and safety in clinical practiceDaniel Goyco Vera, Hiral Waghela, Mohamed Nuh, et al.
Cancer Cell|October 27, 2023
Bringing CAR T cell therapy trials to underserved populationsHoda Badr, Rayne Rouce, Michael E Scheurer, et al.
Plos One|October 8, 2013
Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphomaMarc A Kowalkowski, Martha P Mims, E Susan Amiran, et al.
Blood Advances|January 28, 2020
Evaluation of cyclin A1-specific T cells as a potential treatment for acute myeloid leukemiaWingchi K Leung, Aster Workineh, Shivani Mukhi, et al.
Cancer Immunology Research|September 19, 2022
Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid TumorsPradip Bajgain, Alejandro G Torres Chavez, Kishore Balasubramanian, et al.
Journal for Immunotherapy of Cancer|May 12, 2018
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activationPradip Bajgain, Supannikar Tawinwung, Lindsey D'Elia, et al.
Journal for Immunotherapy of Cancer|November 30, 2019
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevityAlejandro Torres Chavez, Mary Kathryn McKenna, Emanuele Canestrari, et al.
Transplantation and Cellular Therapy|June 3, 2021
Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow ProductsBrennan Parmelee Streck, Georges Naufal, George Carrum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Cancers|March 6, 2021
The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple MyelomaLaure Maneix, Melanie A Sweeney, Sukyeong Lee, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|August 6, 2024
Approved CAR-T therapies have reproducible efficacy and safety in clinical practiceDaniel Goyco Vera, Hiral Waghela, Mohamed Nuh, et al.
Cancer Cell|October 27, 2023
Bringing CAR T cell therapy trials to underserved populationsHoda Badr, Rayne Rouce, Michael E Scheurer, et al.
Plos One|October 8, 2013
Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphomaMarc A Kowalkowski, Martha P Mims, E Susan Amiran, et al.
Blood Advances|January 28, 2020
Evaluation of cyclin A1-specific T cells as a potential treatment for acute myeloid leukemiaWingchi K Leung, Aster Workineh, Shivani Mukhi, et al.
Cancer Immunology Research|September 19, 2022
Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid TumorsPradip Bajgain, Alejandro G Torres Chavez, Kishore Balasubramanian, et al.
Journal for Immunotherapy of Cancer|May 12, 2018
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activationPradip Bajgain, Supannikar Tawinwung, Lindsey D'Elia, et al.
Journal for Immunotherapy of Cancer|November 30, 2019
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevityAlejandro Torres Chavez, Mary Kathryn McKenna, Emanuele Canestrari, et al.
Transplantation and Cellular Therapy|June 3, 2021
Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow ProductsBrennan Parmelee Streck, Georges Naufal, George Carrum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Cancers|March 6, 2021
The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple MyelomaLaure Maneix, Melanie A Sweeney, Sukyeong Lee, et al.
Pageof 4